Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Guselkumab (an IL-23–specific mAb) demonstrates clinical ... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Guselkumab (an IL-23–specific mAb) demonstrates clinical and molecular response in patients with moderate-to-severe psoriasis
0
Authors
Howard Sofen
12 more
Howard Sofen
•
Philippe Szapary
10 more
•
James Krueger
Published
March 28, 2014
Paper
Conversation
0
Reviews
0
Bounties
0
Loading PDF viewer…
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Journal of Allergy and Clinical Immunology
Topics
Medicine
Immunology
Pathology
Physiology
Dermatology
Show all topics
DOI
10.1016/j.jaci.2014.01.025
License
CC-BY-NC-ND
Other Formats
PDF
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Journal of Allergy and Clinical Immunology
Topics
Medicine
Immunology
Pathology
Physiology
Dermatology
Show all topics
DOI
10.1016/j.jaci.2014.01.025
License
CC-BY-NC-ND
Other Formats
PDF
